Hepatitis B: all 1,662 studies
Page 17 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216CompletedNCT00161941
- Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy InfantsCompletedNCT00161928Phase 3
- Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral HepatitisStatus unknownNCT00160940
- Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 MthsCompletedNCT00158808Phase 2
- Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.CompletedNCT00158717
- Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.TerminatedNCT00158704Not applicable
- Studies of Immune Responses in Patients With Chronic Hepatitis BCompletedNCT00155155
- Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular CarcinomaStatus unknownNCT00155103
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531
- Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg NegativeStatus unknownNCT00152880
- Project UNITY - HIV Risk Reduction and Vaccine Education InterventionsCompletedNCT00150098Not applicable
- Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver TransplantationStatus unknownNCT00147459Not applicable
- Post-marketing Safety Study of GSK Biological's Pediarix™ VaccineCompletedNCT00146835
- Long Term Follow-up of Pegylated-Interferon Alpha-2bCompletedNCT00146705
- VaxTeen Hepatitis B Vaccine Booster StudyCompletedNCT00144313Phase 4
- Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025CompletedNCT00142740
- Response to Booster Doses of Hepatitis B Vaccine in Children and AdolescentsCompletedNCT00141999
- Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)CompletedNCT00140725Phase 3
- Pilot Study Freeze and Transport Immune CellsCompletedNCT00138268
- Pentavalent DTaP-Hep B-IPVCompletedNCT00133445Phase 2
- Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
- Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
- Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis BCompletedNCT00128544Phase 2
- Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-InfectionCompletedNCT00127959Phase 4
- Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?CompletedNCT00125775Phase 4
- An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2
- Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)TerminatedNCT00120796Phase 3
- Long-Term Lamivudine Therapy for Chronic Hepatitis BCompletedNCT00120354Phase 4
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaStatus unknownNCT00117533Phase 4
- Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
- 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT00114361Phase 3
- Safety and Acceptability of a Vaginal MicrobicideCompletedNCT00111943Phase 2
- Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected PeopleCompletedNCT00100633Phase 1/2
- Retrovirus Epidemiology Donor Study-II (REDS-II)CompletedNCT00097006
- Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access ProgramNo longer availableNCT00096811
- Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)CompletedNCT00092469Phase 3
- Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis BCompletedNCT00071201Phase 3
- Prevention of Recurrent Hepatitis B After Liver TransplantationCompletedNCT00059267
- A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis BCompletedNCT00057265Phase 3
- Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNCT00051090Not applicable
- Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
- Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected PatientsCompletedNCT00051038Phase 2/3
- Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis BCompletedNCT00048945Phase 3
- A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.Status unknownNCT00044135Phase 2
- An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment OptionsApproved for marketingNCT00042393
- Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis BTerminatedNCT00040144Phase 2
- Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.TerminatedNCT00037622Not applicable
- A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to LamivudineCompletedNCT00036608Phase 3
- A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e AntigenCompletedNCT00035789Phase 3
- A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenCompletedNCT00035633Phase 3
- Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus InfectionCompletedNCT00034359Phase 2
- A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedNCT00033163Phase 2
- Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
- Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
- Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected PatientsCompletedNCT00013702Phase 2
- Epidemiology, Infectivity and Natural History of Hepatitis C Virus InfectionCompletedNCT00004850
- Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in JapanCompletedNCT00001712
- Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 2
- The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAUCompletedNCT00000654Phase 2
- Hepatitis B Vaccine Clinical TrialCompletedNCT00000583Phase 3
- Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune GlobulinCompletedNCT00000580Phase 3